{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-027009","form_type":"8-K","ticker":"SLS","cik":"0001390478","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2023-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.724371+00:00","generated_at":"2026-06-18T17:28:39.657741+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SELLAS closes $18.5M offering; reprices 3.4M warrants to $3.62","bullets":["Closed underwritten offering of 7,220,217 shares and warrants for net proceeds of ~$18.5M.","Amended 3,438,851 warrants issued April 2022, reducing exercise price from $5.40 to $3.62.","New exercise price equals average closing price over five trading days before offering pricing.","Offering and warrant amendments executed on February 28, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-027009","json":"https://secwatch.observer/filing/0001104659-23-027009.json","markdown":"https://secwatch.observer/filing/0001104659-23-027009.md","text":"https://secwatch.observer/filing/0001104659-23-027009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923027009/0001104659-23-027009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923027009/tm238142d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T17:28:39.657741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}